|
Date:
|
Title:
|
|
01/20/06
|
Research: New Compound Stops Brain Cell Degeneration in Alzheimer's Disease?
Drug discovery researchers at Northwestern University have developed a novel orally administered compound specifically targeted to suppress brain cell inflammation and neuron loss associated with Alzheimer's disease.
|
|
10/31/05
|
More than One Million Americans Helped in 6 Months by Private-Sector Drug Program
In just six months, the Partnership for Prescription Assistance (PPA), a national program dedicated to helping people in need access prescription medicines, has matched more than one million patients with assistance programs that likely meet their needs.
|
|
09/07/05
|
Celera Diagnostics Extends Collaboration with Merck in Alzheimer's Disease
Celera Diagnostics, a joint venture between the Celera Genomics Group (NYSE:CRA) and Applied Biosystems Group (NYSE:ABI) of Applera Corporation, today announced the extension of its collaboration with Merck & Co., Inc. aimed at developing new treatments for Alzheimer's disease.
|
|
04/27/05
|
New Drug Program Helps More Than 100,000 Patients in First Three Weeks
A new program that helps patients in need get prescription medicines is generating an outpouring of inquiries from patients nationwide.
|
|
04/01/05
|
FDA MedWatch: Reminyl (galantamine) Precautions Due to Deaths Reported in Clinical Trials
Ortho-McNeil Neurologics modified the PRECAUTIONS section of the Prescribing Information for Reminyl, approved only for the treatment of mild to moderate Alzheimer's Disease. The changes provide new safety information regarding the results of two randomized, placebo-controlled trials of 2 years duration in subjects with mild cognitive impairment(MCI).
|
|
02/24/05
|
Quetiapine speeds up rate of decline in Alzheimers?
Quetiapine, a drug commonly used in nursing homes to treat agitation and related symptoms in people with Alzheimers' disease actually worsens patients' illness, speeding up their rate of decline significantly, says a paper published on bmj.com.
|
|
11/08/04
|
New Compounds Effective Against Alzheimer's Disease Onset and Progression
Drug discovery researchers at Northwestern University have developed a new class of compounds that have the potential to reduce the inflammation of brain cells and the neuron loss associated with Alzheimer's disease.
|
|
11/02/04
|
Jefferson Neuroscientists Studying New Type of Alzheimer’s Drug Aimed at Halting Disease Progression
Researchers hope Alzhemed will prove effective in international clinical trial.
|
|
08/05/04
|
Merck Signs Deals In Oncology And Alzheimer's
Merck and Celera Diagnostics have begun to collaborate to find drug targets and biomarkers for Alzheimer’s disease.
|
|
07/29/04
|
Celera, Merck to Tackle Alzheimer's
Celera Genomics has signed its third big research partnership this month. The company says Merck will help fund research into potential treatments for Alzheimer's disease based of Celera's gene discoveries.
|
